Jesse Goodman - 14 Apr 2025 Form 4/A - Amendment Insider Report for BiomX Inc. (PHGE)

Reporting relationship: Director
Issuer ticker: PHGE
Reported as of: 14 Apr 2025
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 21 Apr 2025, 08:07:44 UTC
Original report date: 18 Apr 2025
Prior SEC filing: 15 Jul 2024
Next SEC filing: 13 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Jesse Goodman

Key filing fact

Jesse Goodman filed Form 4/A - Amendment for BiomX Inc. (PHGE) on 21 Apr 2025.

Key facts

This page summarizes Jesse Goodman's Form 4/A - Amendment filing for BiomX Inc. (PHGE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 21 Apr 2025, 08:07.

Change

Previous filing in this sequence was filed on 15 Jul 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PHGE transaction Derivative

Common Stock Options - right to Buy

Award

Transaction value: $0
Shares: +17,600
Change %
Price: $0.000000
Shares after: 17,600
Date: 14 Apr 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 17,600
Exercise price: $0.5380
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options vest and become exercisable over four years, with 25% of the shares of common stock subject to the option vesting on April 14, 2026, and the reminder vesting in 12 equal quarterly installments over three years.

SEC remarks

This amendment is being filed solely to correct an administrative error in Table II, Column 5. The number of derivative securities acquired was inadvertently reported under (D) of Column 5 instead of (A). No other changes have been made to the originally filed Form 4.